Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001540354-23-000003

CEO and President acquired 91,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rosa David A · CEO and President

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-21 Grant or award : show line 1 in the form +91,500 550,119 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-04-21 Grant or award : show line 2 in the form Option to Purchase Common Stock +91,500 $1.59 2033-04-20 91,500 91,500 D
Loading xslF345X04/primary_doc.xml…